Vitamin D3 and ceramide reduce the invasion of tumor cells through extracellular matrix components by elevating protein phosphatase-2A

Invasion and Metastasis

Volumn 16, Issue 6, 1996, Pages 280-290

  Metz, Raymond J ^b   Vellody, Kishore ^a   Patel, Snehal ^a   Bergstrom, Richard ^b   Meisinger, Jeremy ^a   Jackson, Jodi ^b   Wright, Mark A ^a   Young, M Rita I ^a,b  

^a HINES VA HOSPITAL   (United States)

^b LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

Ceramide; Invasion; Lewis lung carcinoma; Protein phosphatase 2A; Tumor; Vitamin D3

Indexed keywords

CERAMIDE; COLECALCIFEROL; LAMININ; PHOSPHOPROTEIN PHOSPHATASE 2A; VITAMIN D DERIVATIVE; VITRONECTIN; DRUG DERIVATIVE; N ACETYLSPHINGOSINE; N-ACETYLSPHINGOSINE; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE; SPHINGOSINE;

ANIMAL CELL; ARTICLE; CANCER INVASION; CELL LYSATE; CONTROLLED STUDY; ENZYME ACTIVE SITE; ENZYME ACTIVITY; ENZYME SUBUNIT; EXTRACELLULAR MATRIX; GENETIC TRANSFECTION; IMMUNOBLOTTING; LEWIS CARCINOMA; MOUSE; NONHUMAN; SIGNAL TRANSDUCTION; TUMOR CELL; ANIMAL; BIOSYNTHESIS; DRUG EFFECT; ENZYME ACTIVATION; HUMAN; LUNG TUMOR; METABOLISM; METASTASIS; PATHOLOGY; PHYSIOLOGY; WESTERN BLOTTING;

ANIMALS; BLOTTING, WESTERN; CHOLECALCIFEROL; ENZYME ACTIVATION; EXTRACELLULAR MATRIX; HUMANS; LAMININ; LUNG NEOPLASMS; MICE; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; OKADAIC ACID; PHOSPHOPROTEIN PHOSPHATASE; SPHINGOSINE; TRANSFECTION; VITRONECTIN;

EID: 0030299307     PISSN: 02511789     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Young MRI, Lozano Y, Djordjevic A, Maier D: Protein phosphatases limit tumor motility. Int J Cancer 1993;54:1036-1041.
2. Scholar EM, Toews ML: Inhibition of invasion of murine mammary carcinoma cells by the tyrosine kinase inhibitor genistein. Cancer Lett 1994;87:159-162.
3. Silletti S, Paku S, Raz A: Tumor autocrine motility factor responses are mediated through cell contact and focal adhesion rearrangement in the absence of new tyrosine phosphorylation in metastatic cells. Am J Pathol 1996;148:1649-1660.
4. Repesh LA, Drake SR, Warner MC, Downing SW, Jyring R, Seftor EA, Hendrix MJ, McCarthy JB: Adriamycin-induced inhibition of melanoma cell invasion is correlated with decrease in tumor cell motility and increases in focal contact formation. Clin Exp Metastasis 1993;11:91-102.
5. You J, Miele ME, Dong C, Welch DR: Suppression of human melanoma metastasis by introduction of chromosome 6 may be partially due to inhibition of motility, but not to inhibition of invasion. Biochem Biophys Res Commun 1995;208:476-484.
6. Bernstein LR, Liotta LA: Molecular mediators of interactions with extra-cellular matrix components in metastasis and angiogenesis. Curr Opin Oncol 1994;6:106-113.
7. Juliano RL, Varner JA: Adhesion molecules in cancer: The role of integrins. Curr Opin Cell Biol 1994;5:812-818.
8. Timar J, Trikha M, Szekeres K, Bazaz R, Tovari J, Silletti S, Raz A, Honn KV: Autocrine motility factor signals integrin-mediated metastatic melanoma cell adhesion and invasion. Cancer Res 1996;56:1902-1908.
9. 3 coupled to a decline in protein kinase A activity and an increase in cytoskeletal organization. Clin Exp Metastasis 1996;102-110.
10. Young MRI, Charboneau S, Lozano Y, Djordjevic A, Young ME: Activation of the protein kinase A signal transduction pathway by granulocyte-macrophage colony-stimulating factor or by genetic manipulation reduces cytoskeletal organization in Lewis lung carcinoma variants. Int J Cancer 1994;54:446-451.
11. Pokorna E, Jordan PW, O'Neffl CH, Zicha D, Gilbert CS, Vesely P: Actin cytoskeleton and motility in rat sarcoma cell populations with different metastatic potential. Cell Motil Cytoskeleton 1994;28:25-33:
12. Sadano H, Shimokawa-Kuroki R, Taniguchi S: Intracellular localization and biochemical function of variant beta-actin, which inhibits metastasis of B16 melanoma. Jap J Cancer Res 1994;85:735-743.
13. Nabeshima K, Komada N, Inoue T, Koono M: A two-dimensional model of cell movement. Well differentiated human rectal adenocarcinpma cells move as coherent sheets upon TPA stimulation. Pathol Res Pract 1995;191:76-83.
14. Maier GD, Vellody K, Meisinger J, Djordjevic A, Lozano Y, Young MRI: Protein kinase A regulates Lewis lung carcinoma adherence to extracellular matrix components and spontaneous metastasis. Clin Exp Metastasis 1996;14:322.
15. Young MRI, Montpetit M, Lozano Y, Djordjevic A, Devata S, Matthews JP, Yedavalli S, Cheijfec G: Lewis lung carcinoma transfectants that either overexpress or have defective protein kinase A activity have a respective high or low capacity to invade and metastasize in vivo. Int J Cancer 1995;64:104-109.
16. 2-producing nonmetastatic Lewis lung carcinoma variants. Cancer Res 1990;50:2973-2978.
17. Maier GD, Wright MA, Lozano Y, Djordjevic A, Matthews JP, Young MRI: Regulation of cytoskeletal organization in tumor cells by protein phosphatase-1 and -2A. Int J Cancer 1995;61:51-54.
18. 2-protein kinase A signaling and protein phosphatase-1 and -2A regulate, human head and neck squamous cell carcinoma motility, adherence to extracellular matrix components, and cytoskeletal organization, Prostaglandins 1996;51:35-48.
19. 3-induced HL-60 cell differentiation. J Biol Chem 1990;265:15823-15831.
20. 3 in HL-60 cells. Role in cell differentiation. J Biol Chem 1989;264:19076-19080.
21. 2-ceramide. J Biol Chem 1995;270:12808-12813.
22. Dobrowsky RT, Laminayashi C, Mumby MC, Hatinun YA: Ceramide activates heterotrimeric protein phosphatase 2A. J Biol Chem 1993;268:15523-15530.
23. 2-stimulated migration of Lewis lung carcinoma clones. Int J Cancer 1991;49:150-155.
24. Wadzinski BE, Eisfelder BJ, Peruski LF Jr, Mumby MC, Johnson GL: NH2-terminal modification of the phosphatase 2A catalytic subunit allows functional expression in mammalian cells. J Biol Chem 1992;267:16883-16888.
25. Favre B, Zolnierowicz S, Turowski P, Hemmings BA: The catalytic subunit of protein phosphatase 2A is carboxyl-methylated in vivo. J Biol Chem 1994;269:16311-16317.
26. Cohen P: Classification of protein-serine/threonine phosphatases: Identification and quantitation in cell extracts. Methods Enzymol 1991;201:389-427.
27. Dumont JA, Bitonti AJ: Modulation of human melanoma cell metastasis and adhesion may involve integrin phosphorylation mediated through protein kinase C. Biochem Biophys 1994;204:264-272.
28. Ziegler A, Knesel J, Fabbro D, Nagamine Y: Protein kinase C down-regulation enhances cAMP-mediated induction of urokinase-type plasminogen activator mRNA in LLC-PK1 cells. J Biol Chem 1991;266:21067-21074.
29. Bouffard D, Duncan LM, Howard CA, Mihm MC Jr, Byers HR: Actin-binding protein expression in benign and malignant melanocytic proliferations (see comments). Hum Pathol 1994;25:709-714.
30. Gutierrez LM, Quintanar JL, Rueda J, Viniegra S, Reig JA: The protein phosphatase inhibitor calyculiti-A affects catecholamine secretion and granular distribution in cultured adrenomedullary chromaffin cells. Eur J Cell Biol 1995;68:88-95.
31. Guo H, Reddy SAG, Damimi Z: Purification and characterization of an autophosphorylation-activated protein serine threonine kinase that phosphorylates and inactivates protein phosphatase 2A. J Biol Chem 1993;268:11193-11198.
32. Guo H, Damuni Z: Autophosphorylation-activated protein kinase phosphorylates and inactivates protein phosphatase 2A. Proc Natl Acad Sci USA 1993;90:2500-2504.
33. Turowski P, Fernandez A, Favre B, Lamb NJC, Hemmings BA: Differential methylation and altered conformation of cytoplasmic and nuclear forms of protein phosphatase 2A during cell cycle progression. J Cell Biol 1995;129:397-410.
34. Mumby MC, Walter G: Protein serin/threonine phosphatases: Structure, regulation and functions in cell growth. Physiol Rev 1993;73:673-700.
35. Tang DG, Grossi IM, Tang KQ, Diglio CA, Honn KV: Inhibition of TPA and 12(S)-HETE-stimulated tumor cell adhesion by prostacyclin and its stable analogs: Rationale for their antimetastatic effects. Int J Cancer 1995;60:418-425.
36. Scott G, Liang H: pp125FAK in human melanocytes and melanoma: Expression and phosphorylation. Exp Cell Res 1995;219:197-203.
37. Trachsel S, Keller HU: Selective responses (actin polymerization, shape changes, locomotion, pinocytosis) to the PKC inhibitor Ro 31-8220 suggest that PKC discriminately regulates functions of human blood lymphocytes. J Leukoc Biol 1995;57:587-591.
38. Sontag E, Nunbhakdi-Craig V, Bloom GS, Mumby MC: A novel pool of protein phosphatase 2A is associated with microtubules and is regulated during the cell cycle. J Cell Biol 1995;128:1131-1144.